News | September 12, 2007

Lung Cancer Alliance Stands Behind CT Screening

September 13, 2007 - While the American College of Chest Physicians (ACCP) came out this week in opposition to CT screening for lung cancer, Lung Cancer Alliance (LCA) reiterated its support for the screening test, which can detect lung cancer at its earliest most treatable stage for those at high risk.

"Mammograms for breast cancer faced enormous opposition for decades and there is still heated debate over screening of women under the age of 50. And there are reams of papers showing no mortality benefit for PSA testing for prostate cancer," said Laurie Fenton Ambrose, President of Lung Cancer Alliance.

"These scientific debates are not new, especially when it comes to interpreting statistics about the true benefit of screening," she said. "However it is disappointing and frankly shocking that the ACCP would flatly oppose CT screening for those at high risk for lung cancer when even the government health agency responsible for setting diagnostic guidelines is more balanced," she said.

The U.S. Preventive Services Task Force neither supports nor opposes screening for lung cancer, a neutral stance that it also takes on PSA testing for prostate cancer and breast self-exams for breast cancer.

"It is difficult to take the ACCP guidelines seriously when they are dismissive of screening and only endorse massages and acupuncture for a disease as deadly as lung cancer," she said.

The issue of early detection is critical in lung cancer which is the biggest cancer killer, taking more lives each year than breast, prostate, colon and kidney cancers combined. By the time symptoms, such as a cough or bloody sputum, appear it is usually too late and in most cases death occurs in less than a year.

Since last year, LCA has raised questions and concerns about the validity of underlying assumptions and modeling being used to provide the basis for the ACCP practice guidelines.

Harvey Pass MD, Chief of Thoracic Surgery and Thoracic Oncology at NYU School of Medicine, LCA Board member and chair of LCA's Medical and Scientific Advisory Board said: "These guidelines simply dismiss the mounting evidence which continues to mature from the largest international, protocol-driven screening effort (I-ELCAP) showing that CT screening in a high risk population has the potential to reverse the current 15% five year survival rate."

For more information: www.LungCancerAlliance.org

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer
News | Lung Cancer | August 02, 2017
To raise public awareness of lung cancer—the leading cancer killer of men and women—the American Lung Association's...
GE’s DoseWatch is a digital informatics solution that automatically collects, monitors and reports on radiation dose indices for diagnostic imaging exams
News | Radiation Dose Management | July 31, 2017
GE Healthcare announced that it has licensed computed tomography (CT) organ dosimetry technology developed at Duke...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Samsung Introduces FDA-Cleared BodyTom Elite CT Scanner
Technology | Computed Tomography (CT) | July 24, 2017
Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its...
Sponsored Content | Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
ACR Updates Radiation Oncology and Medical Physics Guidance With ASTRO and AAPM
News | Radiation Dose Management | July 19, 2017
July 19, 2017 — The American College of Radiology (ACR) recently collaborated with professional medical societies to
Sponsored Content | Videos | CT Angiography (CTA) | July 19, 2017
Matthew Budoff, M.D., FACC, professor of medicine, David Geffen School of Medicine at UCLA, endowed chair of preventi
Overlay Init